State Medicaid agencies can improve D-SNP financial transparency and reward those D-SNPs that provide the best value to ...

We recently published a list of 10 Tech Stocks with High Upside Potential. In this article, we are going to take a look at ...

Dual eligibles — that is, people eligible for both Medicare and Medicaid — have a wealth of Medicare options. These ...

Synopsys SNPS shares plunged 20.8% over the past year, underperforming the Zacks Computer - Software industry, Zacks Computer ...

Synopsys (SNPS), a company that provides software for designing computer chips, is planning to sell around $10 billion worth of bonds as early ...

Synopsys (NASDAQ:SNPS – Free Report) had its price target decreased by Piper Sandler from $655.00 to $653.00 in a report released on Thursday,Benzinga reports. Piper Sandler currently has an ...

In a report released yesterday, Clarke Jeffries from Piper Sandler maintained a Buy rating on Synopsys (SNPS – Research Report), with a price ...

Synopsys Inc (NASDAQ:SNPS) shares are trading higher premarket reported first-quarter financial results after the market ...

This post was written by Luke Carberry Mogan. SNPS' first-quarter performance is likely to have benefited from the rising adoption of EDA, IP solutions and Synopsys.ai platform. Get a deeper ...

A comprehensive national study examining dementia patient outcomes for Medicare Advantage beneficiaries with Alzheimer's disease and related dementias (ADRD) uncovered key insights into healthcare ...

Synopsys (SNPS) came out with quarterly earnings of $3.03 per share, beating the Zacks Consensus Estimate of $2.81 per share. This compares to earnings of $3.56 per share a year ago. These figures ...